Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
Investopedia9h
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply. The company makes compounded versions of ...
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers Health, Inc. (NYSE:HIMS) announced the acquisition of a California-based peptide facility to enhance its domestic ...
Us Weekly12h
‘Bachelorette’ Alum Jenn Tran and Sasha Farber Dress Up for Date Night at ‘Suits LA’ Premiere
Former Bachelorette Jenn Tran and her boyfriend, Sasha Farber, dressed to impress at the Los Angeles premiere of the new show ...
Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions
The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.
Leerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.
NDTV5d
Did Lana Del Rey Ask Selena Gomez To "Go To Mexico" After Her Viral Video?
On Tuesday morning, after Selena Gomez posted a video of her breaking down over US President Donald Trump's announcement of the deportation of illegal immigrants, the Internet was divided in their ...